EP Wealth Advisors, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
EP Wealth Advisors, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$210,711
-0.4%
5,516
-17.5%
0.00%
-25.0%
Q1 2023$211,512
-32.6%
6,685
+21.2%
0.00%
-33.3%
Q4 2022$313,747
+29.6%
5,514
+0.3%
0.01%
+20.0%
Q2 2022$242,000
-28.6%
5,500
-35.3%
0.01%
-28.6%
Q1 2022$339,000
-0.9%
8,5000.0%0.01%
-12.5%
Q4 2021$342,000
-1.2%
8,5000.0%0.01%
-11.1%
Q3 2021$346,000
-10.4%
8,5000.0%0.01%
-18.2%
Q2 2021$386,000
+9.0%
8,5000.0%0.01%0.0%
Q1 2021$354,000
-2.5%
8,5000.0%0.01%
-15.4%
Q4 2020$363,000
+62.8%
8,5000.0%0.01%
+30.0%
Q3 2020$223,000
-16.8%
8,5000.01%
-9.1%
Q2 2020$268,000
+48.9%
0
-100.0%
0.01%
+22.2%
Q1 2020$180,000
+1.7%
10,0000.0%0.01%
+28.6%
Q4 2019$177,000
+14.2%
10,0000.0%0.01%
-12.5%
Q3 2019$155,000
-9.9%
10,0000.0%0.01%
-27.3%
Q2 2019$172,00010,0000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders